Biotechnology
IO360 Summit Explores CAR-T Cell Therapy Expansion Beyond Blood Cancer
100% left coverage1 source
Biotechnology
First 100 Days
Are you available to predict what happens in Trump's first 100 days?
Day 1
Latest News
Biotechnology
IO360 Summit Explores CAR-T Cell Therapy Expansion Beyond Blood Cancer
100% left coverage1 source
Biotechnology
BioCardia's CardiAMP-HF Trial Shows Two-Year Survival, Reduced Cardiac Events
100% left coverage1 source
Biotechnology
BioCardia's CardiAMP-HF Trial Shows Two-Year Survival, Reduced Cardiac Events
100% left coverage1 source
Biotechnology, FDA
FDA Approves AstraZeneca's Imfinzi for Bladder Cancer Treatment
50% center coverage2 sources
Biotechnology, FDA
FDA Approves AstraZeneca's Imfinzi for Bladder Cancer Treatment
50% center coverage2 sources
Biotechnology, CRISPR
CRISPR Therapeutics COO Julianne Bruno Steps Down April 2025
50% center coverage2 sources
Biotechnology, CRISPR
CRISPR Therapeutics COO Julianne Bruno Steps Down April 2025
50% center coverage2 sources
Biotechnology, Series C
Arbor Biotechnologies secures $73.9 million to advance gene editing therapies
100% left coverage1 source
Biotechnology, Series C
Arbor Biotechnologies secures $73.9 million to advance gene editing therapies
100% left coverage1 source
Biotechnology, CRISPR
Tel Aviv Researchers Use CRISPR to Eliminate 50% of Head and Neck Tumors
100% center coverage1 source
Biotechnology, CRISPR
Tel Aviv Researchers Use CRISPR to Eliminate 50% of Head and Neck Tumors
100% center coverage1 source
Biotechnology, Markets
Bristol Myers Squibb Acquires 2seventy Bio for $286 Million
100% center coverage2 sources
Biotechnology, Markets
Bristol Myers Squibb Acquires 2seventy Bio for $286 Million
100% center coverage2 sources
First 100 Days
Are you available to predict what happens in Trump's first 100 days?
Day 1
Most Reported By
News from Biotechnology
News from Biotechnology